Industries > Pharma > Global Vaccine Contract Manufacturing Market Report 2018-2028

Global Vaccine Contract Manufacturing Market Report 2018-2028

Leading Countries, Technologies and Companies

PUBLISHED: 06 March 2018
PAGES: 150
PRODUCT CODE: PHA0292

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

The global vaccine contract manufacturing market was worth $883.0m in 2017 and is expected to grow at a CAGR of 9.1% from 2017-2022. Visiongain predicts a CAGR of 9.2% for the global vaccine contract manufacturing market over the whole forecast period (2017-2028).
 
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 150-page report you will receive 69 charts– all unavailable elsewhere.

The 150-page report provides clear detailed insight into the global vaccine contract manufacturing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Revenue and growth forecasts to 2028 for the global vaccine market and market shares in 2017 and 2018 of the submarkets: paediatric vaccines, adult vaccines, influenza vaccines and therapeutic vaccines

• Revenue and growth forecasts to 2028 for the global vaccine contract manufacturing market

• Revenue and growth forecasts to 2028 for the leading national markets:
• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan
• Brazil
• Russia
• China
• India
• Rest of the World

Global Vaccine Contract Manufacturing Market Report 2018-2028

• Discussion and profiles of the leading players in the vaccine contract manufacturing market:
• Baxter BioPharma Solutions
• Boehringer Ingelheim
• Catalent
• Charles River Laboratories
• IDT Biologika
• Lonza
• Meridian Life Science
• Sigma Aldrich Fine Chemicals
• Merck
• Synco Bio Partners

• Analysis of what stimulates and restrains the global vaccine contract manufacturing market: Trends and SWOT Analysis

Visiongain’s study is intended for anyone requiring commercial analyses for the global vaccine contract manufacturing market. You find data, trends and predictions.

Buy our report today Global Vaccine Contract Manufacturing Market Report 2018-2028: Leading Countries, Technologies and Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Vaccine Contract Manufacturing Market Report 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Global Vaccine Contract Manufacturing Market Report 2018-2028


Latest Pharma news

“Biological Drug API Manufacturing market set to grow to $11bn by 2025” says Visiongain report

Strengths in the biotech contract manufacturing market, from the perspective of the CMOs, stem from the demand for lower cost manufacturing from companies of all sizes.

07 November 2019

READ

“global radiation oncology market is anticipated to surpass USD 6.5 billion by 2020”, says Visiongain

Growing aging population, urbanization, and growing wealth in low- and middle-income countries such as China and India are anticipated to boost the APAC radiation oncology market.

07 November 2019

READ

“Global Rabies Diagnostics Market is anticipated to surpass USD 1.8 billion by 2020”, says Visiongain

Several international healthcare organizations are working with healthcare organizations to develop and market new detection assays to drive efforts aimed at fighting the disease.

07 November 2019

READ

“Global spinal muscular atrophy (SMA) market is anticipated is to surpass USD 950 Million by 2020”, says Visiongain

Increasing awareness of SMA and increasing numbers of programs to expand treatment options for rare diseases are key factors that are boosting the market growth.

07 November 2019

READ

Categories

Category